Cargando…

Fibroblast growth factor-21 prevents diabetic cardiomyopathy via AMPK-mediated antioxidation and lipid-lowering effects in the heart

Our previous studies showed that both exogenous and endogenous FGF21 inhibited cardiac apoptosis at the early stage of type 1 diabetes. Whether FGF21 induces preventive effect on type 2 diabetes-induced cardiomyopathy was investigated in the present study. High-fat-diet/streptozotocin-induced type 2...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Hong, Feng, Anyun, Lin, Sundong, Yu, Lechu, Lin, Xiufei, Yan, Xiaoqing, Lu, Xuemian, Zhang, Chi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5833682/ https://www.ncbi.nlm.nih.gov/pubmed/29445083 http://dx.doi.org/10.1038/s41419-018-0307-5

Ejemplares similares

Fibroblast Growth Factor 21 Attenuates Diabetes-Induced Renal Fibrosis by Negatively Regulating TGF-β-p53-Smad2/3-Mediated Epithelial-to-Mesenchymal Transition via Activation of AKT
por: Lin, Sundong, et al.
Publicado: (2020)

Physiological and Pharmacological Roles of FGF21 in Cardiovascular Diseases
por: Cheng, Peng, et al.
Publicado: (2016)

Therapeutic Effects of Fibroblast Growth Factor-21 on Diabetic Nephropathy and the Possible Mechanism in Type 1 Diabetes Mellitus Mice
por: Weng, Wenya, et al.
Publicado: (2020)

Low‐dose radiation prevents type 1 diabetes‐induced cardiomyopathy via activation of AKT mediated anti‐apoptotic and anti‐oxidant effects
por: Zhang, Fangfang, et al.
Publicado: (2016)

Zinc Supplementation Prevented Type 2 Diabetes-Induced Liver Injury Mediated by the Nrf2-MT Antioxidative Pathway
por: Yu, Lechu, et al.
Publicado: (2021)

Attenuation of Hyperlipidemia- and Diabetes-Induced Early-Stage Apoptosis and Late-Stage Renal Dysfunction via Administration of Fibroblast Growth Factor-21 Is Associated with Suppression of Renal Inflammation
por: Zhang, Chi, et al.
Publicado: (2013)

Bailcalin Protects against Diabetic Cardiomyopathy through Keap1/Nrf2/AMPK-Mediated Antioxidative and Lipid-Lowering Effects
por: Li, Ran, et al.
Publicado: (2019)

Fibroblast growth factor 21 deletion aggravates diabetes-induced pathogenic changes in the aorta in type 1 diabetic mice
por: Yan, Xiaoqing, et al.
Publicado: (2015)

FGF21 deletion exacerbates diabetic cardiomyopathy by aggravating cardiac lipid accumulation
por: Yan, Xiaoqing, et al.
Publicado: (2015)

Screening Strategies for Thyroid Disorders in the First and Second Trimester of Pregnancy in China
por: Yang, Hong, et al.
Publicado: (2014)

FGF21 promotes ischaemic angiogenesis and endothelial progenitor cells function under diabetic conditions in an AMPK/NAD+‐dependent manner
por: Dai, Qiaoxia, et al.
Publicado: (2021)

Insignificant Effect of Isolated Hypothyroxinemia on Pregnancy Outcomes During the First and Second Trimester of Pregnancy
por: Chen, Liangmiao, et al.
Publicado: (2020)

Fibroblast growth factor 21 inhibition aggravates cardiac dysfunction in diabetic cardiomyopathy by improving lipid accumulation
por: Chen, Cui, et al.
Publicado: (2018)

The Prevention of Diabetic Cardiomyopathy by Non-Mitogenic Acidic Fibroblast Growth Factor Is Probably Mediated by the Suppression of Oxidative Stress and Damage
por: Zhang, Chi, et al.
Publicado: (2013)

Antioxidant, Lipid Lowering, and Membrane Stabilization Effect of Sesamol against Doxorubicin-Induced Cardiomyopathy in Experimental Rats
por: Chennuru, Anusha, et al.
Publicado: (2013)

Fibroblast growth factor 21 in heart failure
por: Tucker, William, et al.
Publicado: (2022)

Cell type-specific over-expression of chromosome 21 genes in fibroblasts and fetal hearts with trisomy 21
por: Li, Chi-Ming, et al.
Publicado: (2006)

FGF21 Reduces Lipid Accumulation in Bovine Hepatocytes by Enhancing Lipid Oxidation and Reducing Lipogenesis via AMPK Signaling
por: Kong, Yezi, et al.
Publicado: (2022)

Fibroblast Growth Factor 21 Stimulates Pancreatic Islet Autophagy via Inhibition of AMPK-mTOR Signaling
por: Cheng, Sam Tsz Wai, et al.
Publicado: (2019)

Ethanolic Extract of Vitis thunbergii Exhibits Lipid Lowering Properties via Modulation of the AMPK-ACC Pathway in Hypercholesterolemic Rabbits
por: Pan, Chun-Hsu, et al.
Publicado: (2012)

Sex and age differences in AMPK phosphorylation, mitochondrial homeostasis, and inflammation in hearts from inflammatory cardiomyopathy patients
por: Barcena, Maria Luisa, et al.
Publicado: (2023)

Serum lipids profiling perturbances in patients with ischemic heart disease and ischemic cardiomyopathy
por: Yang, Lin, et al.
Publicado: (2020)

Inhibition of p53 prevents diabetic cardiomyopathy by preventing early-stage apoptosis and cell senescence, reduced glycolysis, and impaired angiogenesis
por: Gu, Junlian, et al.
Publicado: (2018)

Lower Cerebrospinal Fluid/Plasma Fibroblast Growth Factor 21 (FGF21) Ratios and Placental FGF21 Production in Gestational Diabetes
por: Tan, Bee K., et al.
Publicado: (2013)

Ferroptosis is essential for diabetic cardiomyopathy and is prevented by sulforaphane via AMPK/NRF2 pathways
por: Wang, Xiang, et al.
Publicado: (2022)

The role of FGF21 in type 1 diabetes and its complications
por: Zhang, Jian, et al.
Publicado: (2018)

MicroRNA-130a Is Elevated in Thyroid Eye Disease and Increases Lipid Accumulation in Fibroblasts Through the Suppression of AMPK
por: Hammond, Christine L., et al.
Publicado: (2021)

Fibroblast growth factor 21 Ameliorates diabetes-induced endothelial dysfunction in mouse aorta via activation of the CaMKK2/AMPKα signaling pathway
por: Ying, Lei, et al.
Publicado: (2019)

Cardioprotective effects of fibroblast growth factor 21 against doxorubicin-induced toxicity via the SIRT1/LKB1/AMPK pathway
por: Wang, Shudong, et al.
Publicado: (2017)

Serum Fibroblast Growth Factor 21 Level Is Associated with Aortic Stiffness in Patients on Maintenance Hemodialysis
por: Chiu, Liang-Te, et al.
Publicado: (2022)

Taking Diabetes to Heart—Deregulation of Myocardial Lipid Metabolism in Diabetic Cardiomyopathy
por: Bayeva, Marina, et al.
Publicado: (2013)

Eliciting α7‐nAChR exerts cardioprotective effects on ischemic cardiomyopathy via activation of AMPK signalling
por: Lin, Zhong‐Hao, et al.
Publicado: (2019)

Molecular imaging of fibroblast activation in multiple non-ischemic cardiomyopathies
por: Wang, Jingnan, et al.
Publicado: (2023)

Lower Serum Fibroblast Growth Factor 21 Levels are Associated with Normal Lumbar Spine Bone Mineral Density in Hemodialysis Patients
por: Wu, Yin-Ting, et al.
Publicado: (2020)

Intracellular Oxidant Activity, Antioxidant Enzyme Defense System, and Cell Senescence in Fibroblasts with Trisomy 21
por: Rodríguez-Sureda, Víctor, et al.
Publicado: (2015)

Fibroblast growth factor 21 in metabolic syndrome
por: Yang, Ming, et al.
Publicado: (2023)

Lipid Lowering Effect of Antioxidant Alpha-Lipoic Acid in Experimental Atherosclerosis
por: Amom, Zulkhairi, et al.
Publicado: (2008)

miR-21 in Human Cardiomyopathies
por: Surina,, et al.
Publicado: (2021)

Adiponectin reduces lipid content in chicken myoblasts by activating AMPK signaling pathway
por: Hu, Qingmei, et al.
Publicado: (2022)

Circulating Fibroblast Growth Factor 21 is Associated with Diastolic Dysfunction in Heart Failure Patients with Preserved Ejection Fraction
por: Chou, Ruey-Hsing, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_2rfdaipgps3dhhv8vroqvsk3o2